XK
CHRS icon

Xact Kapitalforvaltning’s Coherus Oncology CHRS Stock Holding History

Xact Kapitalforvaltning’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$165K Hold
10,200
– – ﹤0.01% 1237
2019
Q4 		$184K Hold
10,200
– – ﹤0.01% 1387
2019
Q3 		$207K Hold
10,200
– – ﹤0.01% 1365
2019
Q2 		$225K Buy
+10,200
New +$177K ﹤0.01% 1350

Other funds holding CHRS

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Xact Kapitalforvaltning's CHRS Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Coherus Oncology (CHRS) position steady in Q1 2020 at 10,200 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.

Xact Kapitalforvaltning first reported a position in CHRS in Q2 2019 and has held it in 4 quarters since. The position peaked at $225K in Q2 2019. 186 funds tracked by Wall St. Rank hold CHRS as of Q1 2020.

  • Xact Kapitalforvaltning held 10,200 shares of Coherus Oncology worth $165K as of Q1 2020.
  • Xact Kapitalforvaltning left its Coherus Oncology share count unchanged in Q1 2020.
  • Coherus Oncology made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1237 holding.
  • Xact Kapitalforvaltning first reported a position in Coherus Oncology in Q2 2019 and has held it in 4 quarters since.
  • Xact Kapitalforvaltning's Coherus Oncology position peaked at $225K in Q2 2019.
  • 186 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.